Oric Pharmaceuticals (ORIC) Assets Average (2020 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Assets Average came in at $422.8 million in Q1 2026, up 63.57% YoY from $258.5 million in Q1 2025, and up 0.66% on a QoQ basis from $420.0 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Assets Average (2020 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 7 years of Assets Average data on file, last reported at $422.8 million in Q1 2026.
- Quarterly Assets Average rose 63.57% year-over-year to $422.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $422.8 million (up 63.57% YoY) and the FY2025 annual result came in at $341.5 million, up 29.82% from the prior year.
- Assets Average climbed to $422.8 million in Q1 2026, from $420.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $422.8 million in Q1 2026 to a low of $236.9 million in Q1 2023.
- A 5-year average of $301.1 million and a median of $286.9 million in 2022 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average slipped 20.83% — and 2026, when it jumped 63.57%.
- Tracing ORIC's Assets Average over 5 years: stood at $242.6 million in 2022, then gained by 8.48% to $263.2 million in 2023, then gained by 9.47% to $288.1 million in 2024, then jumped by 45.79% to $420.0 million in 2025, then advanced by 0.66% to $422.8 million in 2026.
- The last three Assets Average figures came in at $422.8 million (Q1 2026), $420.0 million (Q4 2025), and $389.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | 420.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 420.72 Mn |
| Mar 31, 2026 | 422.83 Mn |
| Dec 31, 2025 | 420.04 Mn |
| Sep 30, 2025 | 389.02 Mn |
| Jun 30, 2025 | 294.86 Mn |
| Mar 31, 2025 | 258.50 Mn |
| Dec 31, 2024 | 288.11 Mn |
| Sep 30, 2024 | 315.49 Mn |
| Jun 30, 2024 | 339.85 Mn |
| Mar 31, 2024 | 301.40 Mn |
| Dec 31, 2023 | 263.17 Mn |
| Sep 30, 2023 | 283.08 Mn |
| Jun 30, 2023 | 259.23 Mn |
| Mar 31, 2023 | 236.91 Mn |
| Dec 31, 2022 | 242.59 Mn |
| Sep 30, 2022 | 248.84 Mn |
| Jun 30, 2022 | 267.37 Mn |
| Mar 31, 2022 | 286.85 Mn |
| Dec 31, 2021 | 306.41 Mn |
| Sep 30, 2021 | 291.20 Mn |